OS Therapies (OSTX) Stock Analysis

What OS Therapies does

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.

Key metrics

ETFs linked to OSTX

Broad-market and Healthcare sector ETFs an investor holding OS Therapies is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how OSTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for OS Therapies?

OS Therapies trades under the ticker OSTX on AMEX.

Which exchange is OSTX listed on?

OSTX is listed on AMEX.

What sector does OS Therapies operate in?

OS Therapies is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze OSTX in a portfolio?

PortView shows OSTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.